Serum 14-3-3 Is a Novel Marker That Complements Current Serological Measurements to Enhance Detection of Patients With Rheumatoid Arthritis

Journal of Rheumatology - Canada
doi 10.3899/jrheum.131446
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Journal of Rheumatology

Related search

Procalcitonin Is a Specific Marker for Detecting Bacterial Infection in Patients With Rheumatoid Arthritis

Journal of Rheumatology
RheumatologyAllergyImmunology
2012English

Serum Fetuin-A Levels in Patients With Rheumatoid Arthritis

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2019English

The Use of Interleukin-22 as a Novel Marker of Disease Activity in Female Patients With Rheumatoid Arthritis

Sohag Medical Journal
2018English

Serum Expression of Β-Catenin Is a Potential Detection Marker in Patients With Colorectal Cancer

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

Serological Markers Associated With Disease Activity in Patients With Rheumatoid Arthritis Treated With Rituximab

Journal of International Medical Research
BiochemistryMedicineCell Biology
2016English

Studies on Sialyltransferase in Serum From Patients With Rheumatoid Arthritis.

Ensho
1986English

Serum Pyridinoline Is Associated With Radiographic Joint Erosions in Rheumatoid Arthritis

Archives of Rheumatology
Rheumatology
2019English

Detection of Mycoplasmal Infections in Blood of Patients With Rheumatoid Arthritis

Rheumatology
RheumatologyPharmacology
1999English

Identification of Novel 14-3-3 Residues That Are Critical for Isoform-Specific Interaction With GluN2C to RegulateN-Methyl-d-aspartate (NMDA) Receptor Trafficking

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy